(Q77634527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Y S Lee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Z Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P F Kador

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1811-1819

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

The role of aldose reductase in the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Comparative molecular field analysis of the antitumor activity of 9H-thioxanthen-9-one derivatives against pancreatic ductal carcinoma 03.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

1.7 .ANG. Structure of FR-1, a Fibroblast Growth Factor-Induced Member of the Aldo-Keto Reductase Family, Complexed with Coenzyme and Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Identification of an aldose reductase inhibitor site by affinity labeling

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

(Pyrimidinyloxy)acetic acids and pyrimidineacetic acids as a novel class of aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Quinazolineacetic acids and related analogues as aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Human Aldose Reductase: pK of Tyrosine 48 Reveals the Preferred Ionization State for Catalysis and Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Biological activities and quantitative structure-activity relationships of spiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-triones as aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Aromatic-aromatic interaction: a mechanism of protein structure stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Human kidney aldose and aldehyde reductases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Inhibition of aldehyde reductase by aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

Catalytic mechanism of aldose reductase studied by the combined potentials of quantum mechanics and molecular mechanics

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2898%2900139-4

7 January 2021

10.1016/S0968-0896(98)00139-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839011%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference